This session will review the regulatory landscape, do’s and don’ts, common pitfalls, and the enforcement landscape surrounding generic and biosimilar drug promotion. Attendees will gain insights into key regulatory considerations and factors that should guide their review of generic & biosimilar drug promotional materials, across a range of media.